tiprankstipranks
Trending News
More News >
Oxford Biomedica (otc) (GB:OXB)
:OXB
UK Market

Oxford BioMedica (OXB) Income Statement

Compare
101 Followers

Oxford BioMedica Income Statement

Last quarter (Q2 2025), Oxford BioMedica's total revenue was £73.22M, an increase of 70.04% from the same quarter last year. In Q2, Oxford BioMedica's net income was £-26.36M. See Oxford BioMedica’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 128.80M£ 89.54M£ 139.99M£ 142.80M£ 87.73M
Gross Profit
£ 53.02M£ 39.73M£ 69.18M£ 82.64M£ 46.07M
Operating Expenses
£ 92.40M£ 223.90M£ 120.74M£ 61.71M£ 50.94M
Depreciation and Amortization
£ 23.09M£ 28.71M£ 26.43M£ 12.46M£ 9.62M
EBITDA
£ -14.33M£ -148.62M£ -10.80M£ 33.22M£ 3.92M
Operating Income
£ -39.38M£ -184.17M£ -30.22M£ 20.77M£ -5.69M
Other Income/Expenses
£ -7.89M£ -4.35M£ -15.76M£ -888.00K£ -878.00K
Pretax Income
£ -47.27M£ -188.53M£ -45.98M£ 19.88M£ -6.57M
Net Income
£ -43.19M£ -157.49M£ -39.16M£ 19.01M£ -6.25M
Per Share Metrics
Basic EPS
£ -0.42£ -1.63£ -0.41£ 0.23£ -0.08
Diluted EPS
£ -0.42£ -1.63£ -0.41£ 0.22£ -0.08
Weighted Average Shares Outstanding
103.46M 96.56M 94.83M 83.48M 79.94M
Weighted Average Shares Outstanding (Diluted)
103.46M 96.56M 94.83M 85.62M 79.94M
Currency in GBP

Oxford BioMedica Earnings and Revenue History